carmustine has been researched along with Di Guglielmo Disease in 7 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Murine erythroleukemia cells (MELC) were incubated with BCNU in concentrations from 1 to 160 mu molar." | 1.27 | Interactions of 1-3 bis-(2-chloroethyl)-nitrosourea (NSC 409962) (BCNU) with clone DS19 of murine erythroleukemia cells (MELC). ( Gabelman, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fouillard, L | 1 |
| Labopin, M | 1 |
| Meloni, G | 1 |
| Polge, E | 1 |
| Gorin, NC | 1 |
| Frassoni, F | 1 |
| Reese, JS | 1 |
| Koç, ON | 1 |
| Lee, KM | 1 |
| Liu, L | 1 |
| Allay, JA | 1 |
| Phillips, WP | 1 |
| Gerson, SL | 2 |
| Zielske, SP | 1 |
| Frischer, H | 1 |
| Mellovitz, RL | 1 |
| Ahmad, T | 1 |
| Nora, MV | 1 |
| Flamigni, F | 1 |
| Marmiroli, S | 1 |
| Caldarera, CM | 1 |
| Guarnieri, C | 1 |
| Gabelman, N | 1 |
| Sakurai, M | 1 |
| Sandberg, AA | 1 |
7 other studies available for carmustine and Di Guglielmo Disease
| Article | Year |
|---|---|
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmus | 2004 |
Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Animals; Antigens, CD34; Antineoplastic Agents; Carmustine; Cell Line; Cell Survival; CHO Cells; Cri | 1996 |
Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.
Topics: Antigens, CD34; Carmustine; Cell Line; Cell Separation; Cytokines; DNA Repair; Drug Interactions; Dr | 2002 |
The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Topics: Alcohols; Aldehydes; Biotransformation; Blood; Bone Marrow; Bone Marrow Cells; Carmustine; Chromatog | 1991 |
Effect of sodium arsenite on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells.
Topics: Animals; Arsenic; Arsenites; Carmustine; Cell Line; Cycloheximide; Enzyme Induction; Friend murine l | 1989 |
Interactions of 1-3 bis-(2-chloroethyl)-nitrosourea (NSC 409962) (BCNU) with clone DS19 of murine erythroleukemia cells (MELC).
Topics: Animals; Carmustine; Cell Cycle; Cell Differentiation; Cell Line; Cell Survival; Dimethyl Sulfoxide; | 1986 |
Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bone Marrow Cells; Carmustine; Chromosome Aberratio | 1974 |